deltatrials
Completed PHASE1 INTERVENTIONAL 3-arm NCT03189524

A Study to Investigate Zanubrutinib in Chinese Participants With B-cell Lymphoma

A Phase I Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of BTK Inhibitor BGB-3111 in Chinese Patients With B-cell Lymphoma

Sponsor: BeiGene

Conditions B-cell Lymphoma
Interventions Zanubrutinib
Updated 12 times since 2017 Last updated: Dec 24, 2024 Started: Jul 5, 2016 Primary completion: Aug 26, 2020 Completion: Aug 26, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03189524, this PHASE1 trial focuses on B-cell Lymphoma and remains completed. Sponsored by BeiGene, it has been updated 12 times since 2016, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshotRecruiting~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshotRecruiting~Jan 2019 – ~Aug 2019 · 7 months · monthly snapshotRecruiting~Aug 2019 – ~Dec 2019 · 4 months · monthly snapshotRecruiting~Dec 2019 – ~Aug 2020 · 8 months · monthly snapshotRecruiting~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotActive Not Recruiting~Sep 2021 – ~Nov 2021 · 2 months · monthly snapshotCompleted~Nov 2021 – ~Jul 2024 · 32 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshotCompleted~Jan 2025 – present · 18 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Jan 2025 — Present [monthly]

    Completed PHASE1

  2. Sep 2024 — Jan 2025 [monthly]

    Completed PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  4. Nov 2021 — Jul 2024 [monthly]

    Completed PHASE1

  5. Sep 2021 — Nov 2021 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

▶ Show 7 earlier versions

  1. Jan 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE1

  2. Aug 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  3. Dec 2019 — Aug 2020 [monthly]

    Recruiting PHASE1

  4. Aug 2019 — Dec 2019 [monthly]

    Recruiting PHASE1

  5. Jan 2019 — Aug 2019 [monthly]

    Recruiting PHASE1

  6. Jun 2018 — Jan 2019 [monthly]

    Recruiting PHASE1

  7. Jul 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

    First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • BeiGene
Data source: BeiGene

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations